Picture of Certara logo

CERT — Certara News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapNeutral

Brief: Certara Simcyp® Simulator Results Replace Ten Human Trials For Chronic Myeloid Leukemia (Cml) Therapy Asciminib

March 3 (Reuters) - Certara Inc CERT.O:

CERTARA SIMCYP® SIMULATOR RESULTS REPLACE TEN HUMAN TRIALS FOR CHRONIC MYELOID LEUKEMIA (CML) THERAPY ASCIMINIB

Source text: ID:nGNX12MPg3

Further company coverage: CERT.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Certara

See all news